Skip to content

LFood and drug retail

Loblaw Companies

By

Updated

Not investment advice. Kevin may own this stock. How we value stocks

History
Price
CA$71.45
Discount category
Far above intrinsic value
Analysts
Bullish
Next earnings
Feb 19 · · estimated
Pick status
Research only

In short

Thesis
Investors pay a premium for the steady earnings growth and buybacks of Loblaw, and only several years of EPS growth near its long-term target can earn it.
Gap
Slow. Only several years of adjusted EPS growth near the target of 8% to 10% a year can earn the premium.

Company guidance: 2026 adjusted EPS growth in the high single digits and about $2.4 billion of capital expenditures (, Q3 2026 report to shareholders)

Price history

About

Loblaw Companies (Loblaw) is the largest food and pharmacy retailer in Canada. It operates supermarkets, hard discount stores and drug stores under banners such as Loblaws, Real Canadian Superstore, No Frills, Maxi, T&T and Shoppers Drug Mart, and it sells its own brands President's Choice and no name. Its PC Optimum loyalty program had more than 18 million active members in 2025. At October 10, 2026, Loblaw had 2,540 stores and 74.2 million square feet of retail space, and in Q2 2026 it opened its first T&T store in California.

Loblaw also has businesses in supply chain services, retail media and data, and Lifemark health clinics. On July 1, 2026, it sold President's Choice Bank to EQB Inc. and now owns about 19.9% of EQB. In 2025, a year with one extra week, revenue was C$63,903 million. George Weston Limited owns about 52.6% of the common shares.

The shares trade on the Toronto Stock Exchange. The head office is in Brampton, Ontario. Per Bank is President and Chief Executive Officer.

Thesis

Loblaw trades above its intrinsic value because investors pay for its steady earnings growth, its strong position in Canadian food and pharmacy retail and its large share buybacks. Adjusted diluted EPS from continuing operations rose 11.4% in the first 40 weeks of 2026, and Loblaw bought back 27.3 million shares for C$1,724 million in that time. At its Investor Day on September 9, 2026, Loblaw set a long-term target of adjusted EPS growth of about 8% to 10% a year.

For the shares to earn this price, three things must be true. Discount banners and Shoppers Drug Mart must keep growing their sales, although Food Retail same-store sales grew only 0.6% in Q3 2026 and store traffic fell. Retail earnings must grow faster than sales, as the 2026 outlook says.

The new growth businesses and the share of EQB income must add to earnings, so that their contribution doubles by 2031. The 2026 results and the 2027 outlook, expected in February 2027, are the next test. Slower food sales, more price competition or new rules on grocery prices can make the premium hard to keep.

Checkpoints

  1. Jul 30, 2026Passed
    Q2 2026 results and the 2026 outlookAdjusted EPS growth of 8% or more and a kept outlook pass; a lower outlook fails.Outcome: Adjusted EPS rose 11.9% to C$0.66, and Loblaw kept its 2026 outlook.
  2. Nov 19, 2026Passed
    Q3 2026 results, the first quarter without President's Choice BankAdjusted EPS growth from continuing operations of 8% or more and positive Food Retail same-store sales pass; lower adjusted EPS fails.Outcome: Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and Food Retail same-store sales grew 0.6%.
  3. Feb 19, 2027 · est.Pending
    2026 results and the 2027 outlook2026 adjusted EPS growth in the high single digits and a 2027 outlook in line with the 8% to 10% framework pass; a lower outlook fails.

Every passed and failed checkpoint across all picks

Recent events

  • November 19, 2026Loblaw reported Q3 2026 results, the first quarter without President's Choice Bank. Retail sales rose 3.6% to C$19,857 million, with Food Retail same-store sales growth of 0.6% and Drug Retail same-store sales growth of 4.8%. Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and total adjusted diluted EPS rose 8.8%. Net earnings included a gain of C$401 million on the sale of PC Financial. Loblaw bought back 8.3 million shares for C$524 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits.
  • November 18, 2026Loblaw sold its interest in QHR Technologies, a maker of medical record software, to LGI Healthcare Solutions for about C$236 million in cash. Loblaw will record the gain in Q4 2026.
  • September 30, 2026The Competition Bureau started an investigation of minimum advertised pricing policies of large consumer goods suppliers. Loblaw said that it supports this investigation and the Bureau's review of competition across the food supply chain.
Show 4 older events
  • September 9, 2026At its Investor Day, Loblaw set a long-term financial framework that targets adjusted EPS growth of about 8% to 10% a year. It expects supply chain services, retail media and data, Lifemark, the T&T expansion in the United States and the EQB income to give about 10% of operating income in 2026, and their contribution to double by 2031.
  • July 30, 2026Loblaw reported Q2 2026 results. Retail sales rose 4.1% to C$15,046 million, with Food Retail same-store sales growth of 1.6% and Drug Retail same-store sales growth of 4.6%. Adjusted EPS rose 11.9% to C$0.66. Loblaw bought back 8.8 million shares for C$552 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits.
  • July 1, 2026Loblaw completed the sale of President's Choice Bank and related businesses to EQB Inc. for C$1,234 million, which included 7.2 million EQB shares worth C$963 million and C$235 million in cash. Loblaw now owns about 19.9% of EQB and expects a gain of about C$375 million before tax in Q3 2026.
  • May 6, 2026Loblaw reported Q1 2026 results. Net earnings available to common shareholders rose 18.1% to C$594 million, or C$0.50 per share, and adjusted EPS rose 10.6% to C$0.52. It opened 5 hard discount stores and 8 drug stores.

Risks

Bull case: Adjusted diluted EPS rose 11.4% in the first 40 weeks of 2026, and the long-term target of about 8% to 10% a year with C$1,724 million of repurchases can keep earnings per share growing.

  • Food retail in Canada is very competitive. Other grocers, discount stores and online sellers compete on price, and more sales in discount stores can lower margins. In Q3 2026, Food Retail traffic fell on a same-store basis.
  • Changes to laws and rules, for example on prices, supplier terms or competition, can limit margins.
  • Drug Retail depends on prescription drug prices that governments set. A reduction of generic drug prices or of professional allowances can lower earnings.
  • Loblaw now owns about 19.9% of EQB. Its share of EQB income depends on the results of a bank, which can change with credit losses and interest rates. In Q3 2026, the first credit loss provisions of EQB on the PC Financial loans gave Loblaw a loss of C$26 million from this investment.
  • George Weston Limited owns about 52.6% of the shares and controls Loblaw. Its interests can differ from those of other shareholders.

Key statistics

Market cap
CA$83B
Shares of Apr 30, 2026
Dividend yield
0.9%
Current annual rate, at the price of Nov 20, 2026
52-week range
CA$58.23 – CA$71.45
To Nov 12, 2026
Beta
0.16
Vs S&P 500, 5 years monthly, to Oct 30, 2026
Average volume
1.2M
3 months, to Nov 12, 2026

Balance sheet

Cash
CA$1.0B
Debt
CA$6.1B
Net debt
CA$5.1B
Credit line
CA$1.4B
undrawn, to March 2030

Cash against debt

CashCA$1.0B
DebtCA$6.1B

debt covered by cashnet debt CA$5.1B

Credit ratings

  • S&P BBB+ · stable

Loblaw funds itself with cash flow, debentures and leases. At October 10, 2026, cash and cash equivalents were C$1,049 million, and Loblaw had no short-term investments.

Dividends

Dividend yield
0.9% (current annual rate, at today’s price of CA$71.45)
Paid per share
CA$0.592 in the last 12 months (4 payments)
Current annual rate
CA$0.62 (CA$0.155 × 4 a year)
Latest ex-dividend date
September 15, 2026, CA$0.155 per share

Dividends per share by year

Loblaw Companies dividends per share by year
2016
CA$0.207
2017
CA$0.215
2018
CA$0.2466
2019
CA$0.31
2020
CA$0.32
2021
CA$0.35
2022
CA$0.395
2023
CA$0.4358
2024
CA$0.4963
2025
CA$0.5513

From 2020 to 2025, the dividend grew by about 11.5% a year. From 2016 to 2025, the dividend grew by about 11.5% a year.

Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.

Questions about Loblaw Companies

What does Loblaw Companies do?

Loblaw Companies (Loblaw) is the largest food and pharmacy retailer in Canada. Its market cap is CA$83B at the current price of CA$71.45.

When does Loblaw Companies report earnings next?

This is an estimate: Loblaw Companies may report on February 19, 2027. It last reported results on November 19, 2026.

Is Loblaw Companies stock below its intrinsic value?

Loblaw Companies stock is far above intrinsic value. This is general information, not advice.

What changed recently at Loblaw Companies?

The latest update is from November 19, 2026. Loblaw reported Q3 2026 results, the first quarter without President's Choice Bank.

What are the main risks for Loblaw Companies?

Food retail in Canada is very competitive. Changes to laws and rules, for example on prices, supplier terms or competition, can limit margins. Drug Retail depends on prescription drug prices that governments set.

How much debt and cash does Loblaw Companies have?

At October 10, 2026, Loblaw Companies had CA$6.1B of debt and CA$1.0B of cash.

Does Loblaw Companies pay a dividend?

Yes. The current annual dividend of Loblaw Companies is CA$0.62 per share. That is a dividend yield of 0.9% at the current price of CA$71.45. In the last 12 months, it paid CA$0.592 per share (0.8%). The latest ex-dividend date was September 15, 2026.

Similar companies

  • DANOYDanoneShares: Weak consumer, Regulation and courts
    Intrinsic value
    Below intrinsic value
    Gap
    Can close
  • WMMVYWalmart de MéxicoShares: Weak consumer, Regulation and courts
    Intrinsic value
    Close to intrinsic value (AI estimate)
    Gap
    Slow
  • DGDollar GeneralShares: Weak consumer, Regulation and courts
    Intrinsic value
    Close to intrinsic value
    Gap
    Can close
  • ABEVAmbevShares: Regulation and courts, Weak consumer
    Intrinsic value
    Well below intrinsic value
    Gap
    Can close
  • AXPAmerican ExpressShares: Regulation and courts, Weak consumer
    Intrinsic value
    Below intrinsic value
    Gap
    Can close

Loading your notes…

Read it all? Star L or pass, then go on to the next one.